KR960003724A - 간질환 치료용 약제조성물 - Google Patents
간질환 치료용 약제조성물 Download PDFInfo
- Publication number
- KR960003724A KR960003724A KR1019940017855A KR19940017855A KR960003724A KR 960003724 A KR960003724 A KR 960003724A KR 1019940017855 A KR1019940017855 A KR 1019940017855A KR 19940017855 A KR19940017855 A KR 19940017855A KR 960003724 A KR960003724 A KR 960003724A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- formula
- compound
- weight
- parts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 간질환 치료제로서 유용한 다음 구조식(1)의 비페닐 디메칠 디카복시레이트(DDB)와 다음 구조식(2)의 우르소데옥시콜린산(UDCA)을 함유한 약제조성물에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (5)
- 다음 구조식(1)로 표시되는 비페닐디메칠 디카복시레이트(DDB)와 다음 구조식(2)로 표시되는 우르소데옥시콜린산(UDCA) 및 약제학적으로 허용되는 부형제로 이루어진 것을 특징으로 하는 약제조성물.
- 제1항에 있어서, 상기 구조식(1) 화합물은 폴리소르베이트 80과 폴리에칠렌글리콜 6000를 사용하여 통상의 용융－용매법으로 처리한 것임을 특징으로 하는 약제조성물.
- 제1항에 있어서, 상기 구조식(1) 화합물과 구조식(2) 화합물의 유효량은 각각 7∼30 중량부와 30∼100중량부로 혼합된 것임을 특징으로 하는 약제조성물.
- 제1항에 있어서, 상기 구조식(1) 화합물의 유효량이 25중량부이고, 구조식(2) 화합물의 유효량이 50중량부임을 특징으로 하는 약제조성물.
- 제1항에 있어서, 상기 구조식(2) 화합물의 유효량이 12.5 중량부이고, 구조식(2) 화합물의 유효량이 50중량임을 특징으로 하는 약제 조성물.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019940017855A KR0142809B1 (ko) | 1994-07-23 | 1994-07-23 | 간질환 치료용 약제조성물 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019940017855A KR0142809B1 (ko) | 1994-07-23 | 1994-07-23 | 간질환 치료용 약제조성물 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR960003724A true KR960003724A (ko) | 1996-02-23 |
| KR0142809B1 KR0142809B1 (ko) | 1998-07-15 |
Family
ID=19388643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019940017855A KR0142809B1 (ko) | 1994-07-23 | 1994-07-23 | 간질환 치료용 약제조성물 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR0142809B1 (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100626414B1 (ko) * | 2003-08-27 | 2006-09-20 | 선종건 | 간염 치료용 약제조성물 |
-
1994
- 1994-07-23 KR KR1019940017855A patent/KR0142809B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR0142809B1 (ko) | 1998-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR950014073A (ko) | 이소퀴놀린 | |
| ES8705393A1 (es) | Un procedimiento para preparar un derivado de pirazol (como divisional de la solicitud de patente de invencion n 543.046, presentada el 10.5.85) | |
| KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
| IT1252868B (it) | Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico | |
| DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
| RU95113862A (ru) | Производные пирролопиримидинов, фармацевтическая композиция, промежуточные соединения | |
| KR890011837A (ko) | 디데하이드로 비타민 d₃유도체 | |
| BR9401183A (pt) | Composto e formulação farmacêutica | |
| BR9814498A (pt) | Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica | |
| EA199800013A1 (ru) | Способы минимизации остеопороза | |
| RU2218334C2 (ru) | Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе | |
| ATE107167T1 (de) | Pharmazeutische zubereitungen für neuroschutz, die arylcyclohexylamine enthalten. | |
| KR900009606A (ko) | 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제 | |
| ATE90339T1 (de) | Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel. | |
| KR950703941A (ko) | 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor) | |
| ATE17727T1 (de) | Alkylenverbrueckte guanidinothiazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
| KR960003724A (ko) | 간질환 치료용 약제조성물 | |
| FI834800A0 (fi) | Foerfarande foer framstaellning av dialkylaminoalkoxibensylalkohol-derivat | |
| CA2249756A1 (fr) | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| KR970705999A (ko) | 타목시펜 및 타목시펜 유사체의 자궁향성 효과를 최소화시키는 방법 (a method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs) | |
| KR890008079A (ko) | 치환된 디카복실산- 비스(3, 5- 디카바모일- 2, 4, 6- 트리요오도아닐리드), 이의 제조방법 및 이를 함유하는 x- 선 조영제 | |
| CA2231025A1 (fr) | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| RU95104235A (ru) | Агент для контроля плодовитости и содержащая его фармацевтическая композиция | |
| KR910019974A (ko) | 치환된 인돌 | |
| BR9507135A (pt) | Composto uso do mesmo processo de preparação do mesmo composição farmacêutica e composição cosmética |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| J204 | Request for invalidation trial [patent] | ||
| J121 | Written withdrawal of request for trial | ||
| FPAY | Annual fee payment |
Payment date: 20130403 Year of fee payment: 16 |
|
| FPAY | Annual fee payment |
Payment date: 20140521 Year of fee payment: 17 |
|
| EXPY | Expiration of term |